Therefore, advancements in NGF basic research are highly relevant for potential therapeutic implications in the field of AD neurodegeneration mainly for the most common, sporadic, late-onset forms (Cattaneo and Calissano, 2012; Triaca and Calissano, 2016; Canu et al., 2017). This evidence concerns the gene NGF and Alzheimer disease.